IPC Releases Draft Amendment To Microbial Contamination In Non-Sterile Products

Mumbai : In a bid to control the microbial quality of pharmaceutical products, the Indian Pharmacopoeia Commission (IPC) has come out with a draft amendment to microbial contamination in non-sterile products in Indian Pharmacopoeia (IP) 2022.

The new draft amendment released by IPC on October 26, 2022 introduced changes to enumeration of aerobic microorganisms present in the product as well as modification in microbial contamination in barium sulphate oral suspension, microcrystalline cellulose and starch.

The draft amendment increased the number of colonies for total fungal count to 50 from 25 in the pour-plate method used for enumeration of aerobic microorganisms present in the product. It says, “Then select the plates corresponding to a given dilution and showing the highest number of colonies but less than 250 for aerobic microorganisms and 50 colonies for total fungal count.” Earlier it was 25 colonies for total fungal count.

The draft says barium sulphate oral suspension should be free from contamination of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa, Salmonella species.

Earlier IP stated that the total aerobic viable count is not more than 100 cfu per ml, the total combined molds and yeasts count is not more than 10 cfu per ml. 1 g is free from Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella species.

The new draft amendment says, “The total aerobic viable count is not more than 100 cfu per ml, the total combined molds and yeasts count is not more than 10 cfu per ml. 1 g is free from Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella species.”

The draft added microbial contamination to microcrystalline cellulose after loss on drying. As per the newly added microbial contamination, “The total aerobic viable count is not more than 1000 cfu per g and total fungal count is not more than 100 cfu per g. 1 g is free from Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and 10 g is free from Salmonella and Shigella.”

Similarly, the IPC introduced aerobic viable count and fungal count to microbial contamination of starch. The newly added draft amendment says “The total aerobic viable count is not more than 1000 cfu per g, the total fungal count is not more than 100 cfu per g, determined by plate count. 1 g is free from Escherichia coli and 10 g is free from Salmonella and Shigella.” Earlier aerobic viable count and fungal count were not mentioned in IP.

Furthermore, as the new draft amendment, bacterial endotoxin will be counted in phenylephrine hydrochloride rather than phenylephrine injection. It introduced changes from ‘not more than 25.0 endotoxin units per mg of phenylephrine’ to ‘not more than 25.0 endotoxin units per mg of phenylephrine hydrochloride’ in Phenylephrine Injection monograph in IP 2022. Bacterial endotoxins are a component of the cell wall of gram-negative bacteria.

In August 2022 IPC came up with a revised draft general chapter on microbiology in the IP which included revised bacterial endotoxin, revised effectiveness of antimicrobial preservatives, and revised microbial contamination in non-sterile products.

SOURCE : Pharmabiz
  • Related Posts

    • Pharma
    • December 23, 2024
    • 66 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 94 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt